Search

everythinglearnresearchcommunity

for

Search:↓

Long-term use of pyrithione zinc shampoos remains effective for scalp seborrheic dermatitis, with decreased effectiveness likely due to not following treatment instructions rather than the treatment itself.

Some medications caused temporary health issues that improved after stopping the drugs, but two patients died from liver problems linked to carbamazepine.

Trilostane treatment successfully restored hair growth in a dog with alopecia X.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

The treatment increased total hair count but wasn't significantly better than placebo.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.

High dose methylprednisolone effectively stops hair loss and promotes regrowth in acute diffuse alopecia areata.

Retinoids can help treat skin pigmentation disorders by affecting melanin production.

Trilostane helped a cat with a hormone issue but the cat later died from a kidney infection.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

Lurasidone is effective for bipolar depression and schizophrenia, but more safety data is needed.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.

A kidney transplant patient on cyclosporin experienced unexpected severe hair loss, which improved with treatment adjustments.

Selumetinib effectively reduces tumor size in many children with neurofibromatosis type 1, but can cause skin and hair issues.

Dutasteride is approved to help manage prostate enlargement.

Cyproterone acetate combined with ethinyl estradiol significantly reduced hirsutism in women.

Rituximab treatment led to complete hair regrowth and improved skin in a woman with pemphigus foliaceus.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

A man had bad reactions to a hair loss treatment called DNCB.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

The niosomes effectively target hair follicles for acne treatment.

Taking cyproterone acetate and ethinyl oestradiol for hair loss can lower vitamin B12 levels in women.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.